News & Press
UK Medical Device Approvals Soar in 2025, Driven by Breakthroughs in Neurotechnology and AI
HT Medical Devices2/23/2026·02/23/26🌐 Europe
Summary
The UK saw a 53% increase in medical device approvals in 2025, with neurotechnology and AI driving significant growth. The MHRA met 100% of statutory deadlines for clinical investigation applications, with average approval times of 51 days, nine days faster than the 60-day target. Dementia, Parkinson's disease and epilepsy studies doubled since 2024.
Why it matters
Faster, more predictable regulatory timelines in the UK are attracting neurotechnology companies to conduct first-in-human studies in Britain. The MHRA's performance demonstrates that post-Brexit regulatory reform can successfully drive medical device innovation.
#BCI#Neurostimulation#CE Mark#UK#Europe#Industry
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in